Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Next-gen weight loss drug may be more effective than others

Digest more
Top News
Overview
Highlights
 · 1d
Eli Lilly: Next-gen weight loss drug may be more effective than others
Eli Lilly said its weight loss drug, retatrutide, helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight.

Continue reading

 · 1d · on MSN
Patients on Lilly's next-gen obesity drug lost 28% of body weight, company says
 · 1d
Eli Lilly says its next gen obesity drug is more powerful than Zepbound and Wegovy
 · 23h
European medicines regulator recommends approval for Novo's Wegovy pill
The European Medicines Agency recommended approval ‌for Novo Nordisk's weight-loss pill ‌Wegovy, the regulator said on Friday, ​clearing its path to become the first oral weight-loss drug in Europe, a...

Continue reading

 · 1d
Scales might be tipping to favor Eli Lilly’s newest experimental weight-loss injection
 · 1d
Experimental Drug Yields Dramatic Weight Loss
 · 1d
Retatrutide targets three hormones instead of one, helping trial participants achieve unprecedented levels of weight-loss
“It was impressive to see that every dose of Retatrutide resulted in clinically meaningful weight reduction for nearly all participants, and people with severe obesity on the highest dose lost on aver...

Continue reading

 · 1d
Eli Lilly’s experimental shot cuts body weight by 28% in study
 · 1d
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
8d

New pancreatic cancer drug called a 'miracle.' What is daraxonrasib?

In clinical trials, the drug was shown to almost double the median survival time for patients with pancreatic cancer.
15hon MSN

Gilead's drug wins first-ever US approval for deadly liver infection

May 22 (Reuters) - Gilead Sciences said on Friday that its experimental drug for a rare and deadly liver infection that had no approved treatment has won U.S. approval. Shares of the company were up over 2% in afternoon trading.
9h

US FDA approves Gilead's drug for deadly liver infection

Food and Drug Administration ‌said on Friday it ‌approved Gilead Sciences' drug for a ​rare and deadly liver infection that previously had no approved treatment options. The health regulator ‌cleared Hepcludex ⁠to treat chronic hepatitis delta virus,
9don MSN

US overdose deaths fell again in 2025, but some worry about policy and drug supply changes

About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year, according to preliminary government data.
2d

Amgen Drug Gets New Warnings in Japan After Patient Deaths

The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.
3d

Surprising drug combo could reshape treatment for suicide risk

A new study suggests a single ketamine infusion followed by low-dose buprenorphine significantly sustained reductions in suicidal ideation in adults with major depressive disorder.
AsiaOne
23h

12-year-old girl among 78 arrested for alleged drug abuse; over $200k worth of drugs seized

A total of 78 drug offenders were arrested and drugs worth over $200,000 were seized during an islandwide operation by the Central Narcotics Bureau (CNB).In a news release on Friday (May 22), CNB said it carried out the operation between May 18 and 22,
1don MSN

Biogen, Denali scrap Parkinson's drug after failure in mid-to-late stage study

May 21 (Reuters) - Biogen and Denali Therapeutics said on Thursday they will discontinue development of their Parkinson's drug after it failed to meet the main goal in a mid-to-late stage study. The drug,
  • Privacy
  • Terms